Rutgers Biomedical and Health Sciences
Rutgers Biomedical and Health Sciences is the public academic health enterprise of Rutgers University, integrating eight professional schools, biomedical research, and clinical care delivery across New Jersey. It serves approximately 2.3 million annual patient visits, supports 450+ active clinical trials, and partners with RWJBarnabas Health and University Hospital Newark for clinical operations.
- Company typePrivate
- Founded-
- HeadquartersNewark, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Rutgers Biomedical and Health Sciences does
Rutgers Biomedical and Health Sciences (RBHS) is the health care enterprise of Rutgers, The State University of New Jersey, operating as a public academic health system that integrates biomedical education, translational research, and clinical care delivery. RBHS encompasses eight professional schools — New Jersey Medical School, Robert Wood Johnson Medical School, School of Nursing, Ernest Mario School of Pharmacy, Rutgers School of Dental Medicine, School of Health Professions, School of Public Health, and School of Graduate Studies — plus research institutes and clinical facilities across Newark, New Brunswick, Piscataway, and Blackwood. The enterprise serves approximately 2.3 million annual patient visits, supports 450+ active clinical trials at any given time, and includes 36 faculty fellows of the American Association for the Advancement of Science. RBHS operates as a government state entity under Rutgers University, governed by a Board of Trustees, with no traditional private equity or venture ownership structure.
The underlying technology and research infrastructure includes the Amarel high-performance computing cluster, the Caliburn supercomputer (the most powerful in New Jersey at the time of its 2016 build), the OnCore Clinical Trial Management System used across the enterprise, and Epic EMR integration with partner hospitals. The CINJ Biomedical Informatics platform provides genome-scale analyses, histopathology imaging, cheminformatics, and clinical data warehouse services. NJ ACTS (New Jersey Alliance for Clinical and Translational Science) is the CTSA-funded translational research backbone, aggregating CMS Medicaid/Medicare data, National Death Index data, AHRQ-funded CERTs research, and biobank resources.
RBHS generates revenue through four primary streams: patient care services billed through insurance and public programs, federal research grants (NIH CTSA, ARPA-H, AHRQ), tuition and educational program fees across its schools, and industry-sponsored clinical trials contract revenue managed through the Clinical Trials Office. Pricing is not publicly disclosed as the institution is a public academic health system. Customer segments include patients, medical and health professions students, research faculty and investigators, and staff. Distribution occurs through direct patient care, academic programs, partner-hospital clinical trials (RWJBarnabas Health, University Hospital Newark, St. Peter's University Hospital), and community engagement programs across New Jersey.
Rutgers Biomedical and Health Sciences firmographics
Firmographics- Name
- Rutgers Biomedical and Health Sciences
- Legal name
- Rutgers, The State University of New Jersey
- Website
- https://rbhs.rutgers.edu
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Rutgers Biomedical and Health Sciences is the public academic health enterprise of Rutgers University, integrating eight professional schools, biomedical research, and clinical care delivery across New Jersey. It serves approximately 2.3 million annual patient visits, supports 450+ active clinical trials, and partners with RWJBarnabas Health and University Hospital Newark for clinical operations.
- Ownership category
- akta.pro rank
Rutgers Biomedical and Health Sciences industry classification
Industry- Product category
- Academic Health System
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Offices of Dentists (62121)
- SIC
- Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)
- akta.pro secondary industries
- Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Oncology & Cancer Specialty Hospitals (HLAFAHAC)
Keywords
Where Rutgers Biomedical and Health Sciences is headquartered
LocationHeadquarters
- HQ city
- Newark
- HQ country
- United States
- HQ region
- North America
Offices10 records
Markets served
Rutgers Biomedical and Health Sciences business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Healthcare Services Revenue: Patient care services through Rutgers Health clinical facilities, including approximately 2.3 million annual patient visits across multiple specialties.
- Federal Research Grants: NIH-funded research through NJ ACTS (Clinical and Translational Science Award), ARPA-H funding opportunities, and other federal research grants supporting investigators.
- Tuition and Educational Programs: Revenue from undergraduate, graduate, professional education, and continuing education programs across RBHS schools.
- Clinical Trials Industry Sponsorship: Industry-sponsored clinical trials with budget development, contracting, and post-award management through the Clinical Trials Office.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Rutgers Biomedical and Health Sciences product offering
Product offeringCore offering
Rutgers Biomedical and Health Sciences operates as a public academic health enterprise that delivers medical, nursing, dental, pharmacy, public health, and health professions education across eight schools; runs biomedical and clinical research programs including 450+ active clinical trials; and provides patient care through partner hospitals and Rutgers Health providers, reaching approximately 2.3 million patient visits annually across New Jersey.
Product overview
Rutgers Biomedical and Health Sciences (RBHS) operates as an academic health enterprise combining biomedical education, research, and healthcare delivery. RBHS encompasses multiple schools (New Jersey Medical School, Robert Wood Johnson Medical School, School of Nursing, School of Dental Medicine, School of Public Health, Ernest Mario School of Pharmacy, School of Health Professions, School of Graduate Studies), clinical care facilities, and research institutes. The organization provides education and training programs, conducts clinical research, and delivers patient care through partner hospitals including RWJBarnabas Health and University Hospital. Key operational units include the NJ ACTS (New Jersey Alliance for Clinical and Translational Science) which provides research infrastructure, the Clinical Trials Office offering centralized trial management services, and the Office of Academic & Student Affairs managing educational operations. RBHS does not operate as a single unified software product but rather as a collection of academic, research, and clinical care entities with supporting administrative and research systems.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Education and Training Programs Undergraduate, graduate, professional, and continuing education programs across schools including New Jersey Medical School, Robert Wood Johnson Medical School, School of Nursing, Ernest Mario School of Pharmacy, Rutgers School of Dental Medicine, School of Health Professions, School of Public Health, and School of Graduate Studies, preparing students for careers in healthcare.
- Rutgers Health Patient Care Services Direct patient care across multiple specialties delivered by Rutgers Health providers via partner hospitals including University Hospital Newark, RWJBarnabas Health, and St. Peter's University Hospital, reaching approximately 2.3 million annual patient visits across New Jersey.
- Clinical Trials Office (CTO) Services Centralized clinical trial administration including study startup, budget development, contracting, post-award management, and OnCore CTMS tracking for 450+ active clinical trials across RBHS and partner hospital locations.
- NJ ACTS Clinical and Translational Science Services CTSA-funded research infrastructure services including biostatistics, epidemiology, biomedical informatics, biobanking, community engagement, pilot funding, and access to the NCATS Trial Innovation Network for multicenter translational research.
- Office of Advanced Research Computing (OARC) Services Advanced research computing services including the Amarel high-performance computing cluster and Caliburn supercomputer, providing training, regulated data environment support, and industry partnerships for computational research.
- CINJ Biomedical Informatics Services Comprehensive biomedical informatics platform providing genome-scale analyses, microarray database and analysis, CINJ warehouse services, clinical data repository, histopathology imaging, cheminformatics analysis, and clinical data warehouse with EMR integration.
- Rutgers Health Community Engagement Programs Community health initiatives including the Rutgers Health Service Corps community service program, Rutgers Health Food Pantry in Newark, and the Rutgers Equity Alliance for Community Health serving New Jersey communities.
Quantifiable outcome
- 2.3 million annual patient visits
- +2 more outcomes
Companies that use Rutgers Biomedical and Health Sciences
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Rutgers Biomedical and Health Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Rutgers Biomedical and Health Sciences partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- RWJBarnabas HealthcoreStrategic clinical partnership combining Rutgers' academic research capabilities with RWJBarnabas Health's clinical delivery network. Jointly operates Rutgers Cancer Institute. The partnership integrates New Jersey Medical School and Robert Wood Johnson Medical School into a unified Rutgers School of Medicine. Clinical Trials Office facilitates non-oncology research at RWJBarnabas locations.
- University Hospital NewarkcoreUniversity Hospital is a partner facility for Rutgers Health faculty conducting clinical research. The CTO facilitates clinical research approval and implementation at University Hospital locations. Rutgers faculty provide clinical services at the hospital.
- St. Peter's University HospitalminorCollaborating institution in the NIH-funded ECHO (Environmental influences on Child Health Outcomes) study, recruiting and following pregnant participants and their offspring in New Brunswick, NJ.
- Princeton UniversitycoreLong-standing research collaboration through NJ ACTS consortium. Princeton neuroscience faculty co-lead Team Science initiatives. Collaborative studies include Fragile Families Third Generation cohort, Corona Cohort, and Tourette International Collaborative Genetics Study.
- Epic Systems CorporationcoreEpic EMR systems are used at partner hospitals (University Hospital Newark and RWJBarnabas Health). Rutgers researchers request access to Epic for research purposes through designated processes and CAM (Centralized Access Management) requests.
- NCATS Trial Innovation NetworkcoreNJ ACTS participates in the NCATS-supported Trial Innovation Network, providing cost-free consultation to investigators wishing to leverage the CTSA network for multicenter trial conduct.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Rutgers Biomedical and Health Sciences competitors and assessment
Company assessmentDirect peers
- Penn Medicine (University of Pennsylvania Health System): Integrated academic medical center with medical school, nursing school, and owned hospital system conducting high-volume translational research. Comparable research intensity and clinical trial throughput.
- NYU Langone Health: Large academic medical center in New York City combining medical education, biomedical research, and an extensive clinical delivery network. Highly comparable tripartite mission, faculty practice structure, and large clinical trial portfolio.
- Columbia University Irving Medical Center: New York City-based academic medical center integrating research, medical/dental/nursing education, and patient care through NYP-affiliated hospitals. Comparable structure of schools, research institutes, and hospital partnerships.
- Weill Cornell Medicine: Private research-intensive medical school in NYC with affiliated NewYork-Presbyterian Hospital, focused on translational research and graduate medical education. Directly comparable medical education plus research model.
- Thomas Jefferson University / Jefferson Health: Philadelphia-based academic health system combining medical/nursing/health professions education with hospital-based clinical care and research. Comparable mid-Atlantic AMC scale and structure.
- Icahn School of Medicine at Mount Sinai: Academic medical school within the Mount Sinai Health System offering MD/PhD training, biomedical research, and clinical care across multiple NYC hospitals. Mirrors RBHS's research-clinical-education integration.
- Albert Einstein College of Medicine: NYC-based medical school with extensive NIH-funded biomedical research portfolio and clinical training through Montefiore Health System. Comparable research-and-education orientation.
- University of Pittsburgh School of Medicine / UPMC: Major public-affiliated academic medical enterprise combining medical school, biomedical research, and a large integrated delivery network. Comparable scale and tri-partite mission.
Regional players
- Hackensack Meridian Health: Largest New Jersey-based health system operating multiple hospitals across the state. Geographically overlapping with RBHS's clinical footprint and a potential partnership/competitor in NJ clinical market.
Others
- Rutgers Cancer Institute of New Jersey: NCI-designated Comprehensive Cancer Center within RBHS; relevant ecosystem peer for oncology research, clinical trial activity, and population health studies across New Jersey.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Rutgers Biomedical and Health Sciences social profiles
Digital presenceRutgers Biomedical and Health Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rutgers Biomedical and Health Sciences leadership team
Management profileNumber of profiles
Profiles12 records
Rutgers Biomedical and Health Sciences subsidiaries and ownership
Company hierarchySubsidiaries9 records
Rutgers Biomedical and Health Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rutgers Biomedical and Health Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rutgers Biomedical and Health Sciences
What does Rutgers Biomedical and Health Sciences do?
Rutgers Biomedical and Health Sciences operates as a public academic health enterprise that delivers medical, nursing, dental, pharmacy, public health, and health professions education across eight schools; runs biomedical and clinical research programs including 450+ active clinical trials; and provides patient care through partner hospitals and Rutgers Health providers, reaching approximately 2.3 million patient visits annually across New Jersey.
Is Rutgers Biomedical and Health Sciences a public or private company?
Rutgers Biomedical and Health Sciences is a private company. It is classified as state government owned and is currently operating.
When was Rutgers Biomedical and Health Sciences founded?
Rutgers Biomedical and Health Sciences was founded in -1. It employs 51 to 100 people.
Where is Rutgers Biomedical and Health Sciences based?
Rutgers Biomedical and Health Sciences is headquartered in Newark, United States, in the North America region.
How does Rutgers Biomedical and Health Sciences make money?
Four revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are federal Research Grants, tuition and Educational Programs and clinical Trials Industry Sponsorship.
Who are Rutgers Biomedical and Health Sciences's main competitors?
Direct peers on record are Penn Medicine (University of Pennsylvania Health System), NYU Langone Health, Columbia University Irving Medical Center, Weill Cornell Medicine, Thomas Jefferson University / Jefferson Health, Icahn School of Medicine at Mount Sinai, Albert Einstein College of Medicine and University of Pittsburgh School of Medicine / UPMC. Hackensack Meridian Health is listed as a regional player. Rutgers Cancer Institute of New Jersey is listed as an others.
Does Rutgers Biomedical and Health Sciences have an API?
No public API is recorded for Rutgers Biomedical and Health Sciences.
What industry is Rutgers Biomedical and Health Sciences in?
Rutgers Biomedical and Health Sciences's product category is Academic Health System. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 622310 and its SIC code is 8060.